Cargando…

554. A Candidate SARS-Associated Coronavirus Vaccine Elicits Broad Immunity in Monkeys

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Gene Therapy. Published by Elsevier Inc. 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129855/ http://dx.doi.org/10.1016/j.ymthe.2004.06.471

Ejemplares similares

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
por: Joyce, M. Gordon, et al.
Publicado: (2021)

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
por: Joyce, M. Gordon, et al.
Publicado: (2021)

Effects of a SARS-associated coronavirus vaccine in monkeys
por: Gao, Wentao, et al.
Publicado: (2003)

564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity
por: Joyce, M G, et al.
Publicado: (2021)

Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
por: Zhang, Yi-Nan, et al.
Publicado: (2021)

CCNA Security 640-554 quick reference
por: Sequeira, Anthony
Publicado: (2012)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection
por: Olivera-Ugarte, Santa-Mariela, et al.
Publicado: (2022)

Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
por: Zhang, Yi-Nan, et al.
Publicado: (2021)

Stabilized coronavirus spike stem elicits a broadly protective antibody
por: Hsieh, Ching-Lin, et al.
Publicado: (2021)

Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
por: Zhou, Jun, et al.
Publicado: (2005)

554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection
por: Mann, Inderjit, et al.
Publicado: (2021)

FRI554 Pretibial Myxedema Associated With Hashimoto Thyroiditis Treated With Teprotumumab
por: Marta Niedzialkowska, Ewelina, et al.
Publicado: (2023)

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022)

Correction to Lancet Oncol 2012; 13: 549, 554
Publicado: (2013)

CCNA Security 640-554 Official Cert Guide
por: Barker, Keith
Publicado: (2012)

CCNA Security (640-554) Portable Command Guide
por: Vachon, Bob
Publicado: (2012)

CCNA Security 640-554 official cert guide
por: Barker, Keith, et al.
Publicado: (2013)

Adenoviral SARS vaccine induces immune responses in monkeys
Publicado: (2013)

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
por: Liang, Qingtai, et al.
Publicado: (2022)

Looking for God in a busted particle (PRESSCUT-S-2005-554)
por: Calamai, Peter
Publicado: (2005)

Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology
por: Hills, Rory A., et al.
Publicado: (2023)

Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine Candidates
por: Wu, Yixin, et al.
Publicado: (2022)

Disease-Associated Mutation A554V Disrupts Normal Autoinhibition of DNMT1
por: Switzer, Rebecca L., et al.
Publicado: (2023)

Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows
por: Sok, Devin, et al.
Publicado: (2017)

SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
por: Ahmed, Yousuf, et al.
Publicado: (2017)

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern
por: Komori, Mai, et al.
Publicado: (2023)

Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2
por: Luo, Mengxiao, et al.
Publicado: (2023)

Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
por: Kang, Chang Kyung, et al.
Publicado: (2022)

Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants
por: Liu, Yubin, et al.
Publicado: (2023)

Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development
por: Khalaj-Hedayati, Atin
Publicado: (2020)

Mosaic Vaccines Elicit CD8+ T lymphocyte Responses in Monkeys that Confer Enhanced Immune Coverage of Diverse HIV Strains
por: Santra, Sampa, et al.
Publicado: (2010)

SAT-554 Genetic Profile of Early-Onset Aldosterone-Producing Adenomas
por: Baker, Jessica E, et al.
Publicado: (2020)

SAT554 Follicular Variant of PTCA Initially Presenting with Widespread Metastases
por: Natividad Bisquera, Nichole Andrea, et al.
Publicado: (2023)

Computational design of a broad-spectrum multi-epitope vaccine candidate against seven strains of human coronaviruses
por: Kumar, Avinash, et al.
Publicado: (2022)

Decreased Expression of ZNF554 in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival
por: Balogh, Andrea, et al.
Publicado: (2020)

Candidate Genes Associated with Susceptibility for SARS-Coronavirus
por: Hsieh, Ying-Hen, et al.
Publicado: (2009)

Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
por: McCoy, Laura E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_96cnp67rih30ibcn84q6t656tm